According to an article in the New York Times, defendant Merck appears battered at the mid-point of the Texas Vioxx trial. Excerpt:
ANGLETON, Tex., Aug. 5 – Ernst v. Merck, the first Vioxx-related lawsuit to come to trial, is not over yet. But as the company begins to present its case after 14 days of testimony from plaintiffs, Merck appears to be in a deep hole.